Medications

Landmark US opioid trial begins in Oklahoma

The first civil trial that could end up holding a drug company responsible for the US opioid epidemic began Tuesday in Oklahoma, in a landmark case that might impact thousands of others like it.

Medications

Pharmaceutical company Celgene settles suit for $280 million

Celgene Corp. has agreed to pay $280 million to settle a whistleblower lawsuit alleging the pharmaceutical company committed fraud promoting a drug with a notorious history that was re-purposed to treat leprosy and another ...

Other

Court ruling potentially threatens physicians' immunity

(HealthDay)—A court ruling allowing a civil rights lawsuit against a medical examiner may have serious consequences for physicians in public service, according to a report published by the American Medical Association.

Oncology & Cancer

Research finds talc doesn't cause cancer; juries disagree

Two lawsuits ended in jury verdicts worth $127 million. Two others were tossed out by a judge who said there wasn't reliable evidence that the talc in Johnson & Johnson's iconic baby powder causes ovarian cancer. So who's ...

Health

Malpractice concerns affect derm-path interpretive behavior

(HealthDay)—Many dermatopathologists believe that malpractice concerns may lead to additional testing in their evaluation of cutaneous melanocytic lesions, according to research published in the February issue of the Journal ...

page 3 from 13